ASX:PXS (Australia)  
Pharmaxis Ltd logo

Pharmaxis Ltd

A$ 0.06 (0%) Nov 30
On watch
P/E:
At Loss
P/B:
3.15
Market Cap:
A$ 39.98M ($ 26.89M)
Enterprise V:
A$ 35.33M ($ 23.76M)
Volume:
682.18K
Avg Vol (2M):
364.59K
Also Trade In:
Volume:
682.18K
Market Cap A$:
39.98M
Market Cap $:
26.89M
PE Ratio:
At Loss
Avg Vol (2-Month):
364.59K
Enterprise Value A$:
35.33M
Enterprise Value $:
23.76M
PB Ratio:
3.15
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2.08
Equity-to-Asset 0.43
Debt-to-Equity 0.4
Debt-to-EBITDA -0.35
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -21.28
Distress
Grey
Safe
Beneish M-Score 0.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 30.63
9-Day RSI 36.59
14-Day RSI 37.94
6-1 Month Momentum % -24.1
12-1 Month Momentum % -37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.15
Quick Ratio 2.77
Cash Ratio 1.47
Days Inventory 432.42
Days Sales Outstanding 142.93
Days Payable 333.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.7

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 7.426
EPS (TTM) (A$) -0.003
Beta 0.46
Volatility % 50.65
14-Day RSI 37.94
14-Day ATR (A$) 0.002183
20-Day SMA (A$) 0.0652
12-1 Month Momentum % -37
52-Week Range (A$) 0.062 - 0.125
Shares Outstanding (Mil) 634.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pharmaxis Ltd Filings

Document Form Filing Date
No Filing Data

Pharmaxis Ltd Analysis

Share your research